Stoke Therapeutics (STOK) Return on Sales Growth (3y) (2025 - 2026)
Stoke Therapeutics (STOK) Return on Sales Growth (3y) (2025 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,769.80 Bn | 1,769.74 Bn | - | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 3 | BeOne Medicines | 473.64 Bn | 468.85 Bn | 1.35 Bn | 1.00 |
| 4 | Vertex Pharmaceuticals | 123.74 Bn | 116.49 Bn | 2.59 Bn | 0.00 |
| 5 | Regeneron Pharmaceuticals | 71.73 Bn | 62.97 Bn | 3.31 Bn | 0.00 |
| 6 | Belite Bio | 62.10 Bn | 62.10 Bn | - | - |
| 7 | Argenx Se | 54.68 Bn | 49.49 Bn | 1.41 Bn | 1.00 |
| 8 | Alnylam Pharmaceuticals | 38.13 Bn | 35.12 Bn | 959.66 Mn | 1.00 |
| 9 | Revolution Medicines | 36.21 Bn | 36.21 Bn | - | - |
| 10 | Stoke Therapeutics | 1.82 Bn | 1.47 Bn | - | -3.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.00 |
| Dec 31, 2025 | -6.00 |
| Sep 30, 2025 | 6.00 |
| Jun 30, 2025 | 8.00 |
| Mar 31, 2025 | 9.00 |